Evaluation of a superabsorbent dressing in a primary care organization.
This 40-patient evaluation of superabsorbent dressing DryMax Extra (Aspen Medical) was conducted within a large UK primary care organization adhering to an agreed evaluation protocol as approved by clinical governance. Exudate management and key performance requirements of absorbent dressings are considered with an analysis made of the clinical data relating to DryMax Extra. Clinical expectation of the product was rated and met in 38 of 40 cases, relating to ease of use, patient comfort, exudate management, maceration prevention, wear time and visual improvement of the wound bed. Additionally, evaluation findings resulted in a recommendation for formulary listing in 34 cases. Consequently, the authors recommend that there is a need for a large comparative study of the clinical and financial outcomes of superabsorbent dressings.